Affle 3i Limited | Business Upturn

Affle 3i grants 65,880 stock options under employee scheme

Kinjal — Thu, 07 May 2026 11:26:35 +0000

Affle 3i Limited has announced the grant of 65,880 stock options to eligible employees under its Employee Stock Option Scheme – 2021. The options, which cover 65,880 equity shares of face value ₹2 each, were granted effective May 7, 2026.

The scheme is in compliance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The exercise price for these options will be based on the closing market price of the company’s shares on the National Stock Exchange on May 6, 2026.

According to the vesting schedule, 25% of the options will vest 12 months from the grant date, another 25% will vest at 24 months, a further 25% at 36 months, and the remaining 25% will vest at 48 months from the date of grant. Employees will have a one-year period from the vesting date to exercise their options.

As of now, there have been no options exercised, no money realised from the exercise of options, and no shares have arisen from the exercise of options. Additionally, there have been no lapses, variations, or cancellations of the options.

Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).

Affle 3i issues 39,000 equity shares under employee stock option scheme

Yash Agarwal — Fri, 10 Apr 2026 10:06:14 +0000

Affle 3i Limited has announced the allotment of 39,000 equity shares with a face value of ₹2 each to its Employees’ Welfare Trust. This move is part of the company’s Employee Stock Option Scheme, 2021, and took place on 10 April 2026.

As a result of this allotment, the company’s issued, subscribed, and paid-up share capital has increased to ₹281,592,768. This capital is now divided into 140,796,384 equity shares, each with a face value of ₹2.

Affle 3i Limited is in the process of applying for the listing of these newly allotted shares on the National Stock Exchange of India (NSE) and BSE Limited. The company has clarified that this allotment is not considered material in nature.

This update complies with Regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015.

Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).

Affle 3i secures patent for blockchain-based fraud mitigation technology

Kinjal — Wed, 25 Mar 2026 14:43:41 +0000

Affle 3i Limited has been granted a new patent in India for its blockchain-based fraud mitigation technology, which was previously patented in the United States. This development enhances the company’s AI-powered consumer platform stack by establishing a decentralised repository of fraudulent IP addresses and publishers.

The patented technology provides a blockchain-enabled, decentralised shared repository for fraud intelligence across the digital advertising ecosystem. It allows authorised participants to securely record, verify, and act on suspicious traffic signals in real time. By capturing and analysing real-time and historical ad interaction data, the system applies scoring and validation mechanisms to identify potentially fraudulent IP addresses, device IDs, device types, and publishers. These are then classified into shared blacklist or whitelist repositories for coordinated fraud mitigation.

This innovative framework is designed to enhance trust and reliability across the digital advertising ecosystem. It distinguishes genuine from non-genuine engagements, reduces invalid traffic and inefficient ad spends, and enables more authentic, cost-efficient, and measurable consumer outcomes across connected devices.

Affle 3i’s commitment to innovation-led technology development is reflected in this patent grant, which strengthens its fraud intelligence capabilities and enhances the efficiency, authenticity, and future-readiness of its AI-powered consumer platform stack. As of now, the company holds 18 unique patents out of a total IP portfolio of 39 unique patents, with over 300 unique patent claims.

Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).